BMC Medical Genomics (Oct 2022)

Implementation of individualised polygenic risk score analysis: a test case of a family of four

  • Manuel Corpas,
  • Karyn Megy,
  • Antonio Metastasio,
  • Edmund Lehmann

DOI
https://doi.org/10.1186/s12920-022-01331-8
Journal volume & issue
Vol. 15, no. S3
pp. 1 – 18

Abstract

Read online

Abstract Background Polygenic risk scores (PRS) have been widely applied in research studies, showing how population groups can be stratified into risk categories for many common conditions. As healthcare systems consider applying PRS to keep their populations healthy, little work has been carried out demonstrating their implementation at an individual level. Case presentation We performed a systematic curation of PRS sources from established data repositories, selecting 15 phenotypes, comprising an excess of 37 million SNPs related to cancer, cardiovascular, metabolic and autoimmune diseases. We tested selected phenotypes using whole genome sequencing data for a family of four related individuals. Individual risk scores were given percentile values based upon reference distributions among 1000 Genomes Iberians, Europeans, or all samples. Over 96 billion allele effects were calculated in order to obtain the PRS for each of the individuals analysed here. Conclusions Our results highlight the need for further standardisation in the way PRS are developed and shared, the importance of individual risk assessment rather than the assumption of inherited averages, and the challenges currently posed when translating PRS into risk metrics.

Keywords